Clinical Trial Update: A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating mesothelin-directed autologous T cells for advanced pancreatic cancer. The document provides sponsor and condition details b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Mesothelin Redirected Autologous T Cells

Snippet

Sponsor: Shanghai GeneChem Co., Ltd. | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN